Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Lexaria Bioscience (LEXX) Receivables - Other (2017)

Lexaria Bioscience's Receivables - Other history spans 1 years, with the latest figure at $11800.0 for Q3 2017.

Quarterly results put Receivables - Other at $11800.0 for Q3 2017, changed N/A from a year ago — trailing twelve months through Aug 2017 was $11800.0 (changed N/A YoY), and the annual figure for FY2017 was $11800.0, changed.
Receivables - Other for Q3 2017 was $11800.0 at Lexaria Bioscience.
In the past five years, Receivables - Other ranged from a high of $11800.0 in Q3 2017 to a low of $11800.0 in Q3 2017.